Cardiome Appoints William Hunter Permanent President and CEO

Cardiome Pharma (NASDAQ: CRME ) oday announces changes to the company's senior management team. William Hunter, M.D., previously interim Chief Executive Officer and Director, has been appointed full time President and Chief Executive Officer; Karim Lalji has been promoted from Senior Vice President of Commercial Affairs to Chief Commercial Officer;